{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:59:34Z","timestamp":1780657174069,"version":"3.54.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.jconrel.2021.11.048","type":"journal-article","created":{"date-parts":[[2021,12,3]],"date-time":"2021-12-03T12:30:48Z","timestamp":1638534648000},"page":"414-430","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes"],"prefix":"10.1016","volume":"341","author":[{"given":"Maria Helena","family":"Macedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreia S.","family":"Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina C.","family":"Barrias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Sarmento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.11.048_bb0005","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1359-6446(97)01099-4","article-title":"Managing the drug discovery\/development interface","volume":"2","author":"Kennedy","year":"1997","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0010","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1359-6446(01)01712-3","article-title":"Screening for human ADME\/Tox drug properties in drug discovery","volume":"6","author":"Li","year":"2001","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmaceutics11080411","article-title":"Intestinal permeability and drug absorption: predictive experimental, computational and in vivo approaches","volume":"11","author":"Dahlgren","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1208\/s12248-008-9027-6","article-title":"In vitro studies are sometimes better than conventional human pharmacokinetic in vivo studies in assessing bioequivalence of immediate-release solid oral dosage forms","volume":"10","author":"Polli","year":"2008","journal-title":"AAPS J."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0025","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2174\/138920008786485119","article-title":"Permeability for intestinal absorption: Caco-2 assay and related issues","volume":"9","author":"Press","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0030","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/(SICI)1520-6017(200001)89:1<63::AID-JPS7>3.0.CO;2-6","article-title":"Caco-2 versus Caco-2\/HT29-MTX co-cultured cell lines: Permeabilities via diffusion, inside- and outside-directed carrier-mediated transport","volume":"89","author":"Hilgendorf","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0035","doi-asserted-by":"crossref","first-page":"13708","DOI":"10.1038\/srep13708","article-title":"Robust bioengineered 3D functional human intestinal epithelium","volume":"5","author":"Chen","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0040","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jconrel.2015.07.020","article-title":"Life in 3D is never flat: 3D models to optimise drug delivery","volume":"215","author":"Fitzgerald","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0045","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2020.524018","article-title":"Development of an improved 3D in vitro intestinal model to perform permeability studies of Paracellular compounds","volume":"8","author":"Macedo","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0050","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1089\/ten.tec.2012.0463","article-title":"Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation","volume":"19","author":"Li","year":"2013","journal-title":"Tissue Eng. Part C Meth."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.isci.2018.03.015","article-title":"Bioprinted 3D primary human intestinal tissues model aspects of native physiology and ADME\/Tox functions","volume":"2","author":"Madden","year":"2018","journal-title":"iScience"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biomaterials.2015.03.054","article-title":"Dissecting stromal-epithelial interactions in a 3D in vitro cellularized intestinal model for permeability studies","volume":"56","author":"Pereira","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s13206-017-1307-8","article-title":"Three-dimensional in vitro gut model on a villi-shaped collagen scaffold","volume":"11","author":"Yi","year":"2017","journal-title":"BioChip J."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0070","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/j.drudis.2014.05.003","article-title":"Three dimensional human small intestine models for ADME-Tox studies","volume":"19","author":"Yu","year":"2014","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0075","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/bit.24518","article-title":"In vitro 3D human small intestinal villous model for drug permeability determination","volume":"109","author":"Yu","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0080","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1124\/dmd.110.037721","article-title":"Cytochrome P450-dependent metabolism in HepaRG cells cultured in a dynamic three-dimensional bioreactor","volume":"39","author":"Darnell","year":"2011","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0085","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.addr.2013.12.002","article-title":"Tissue-engineered kidney disease models","volume":"69-70","author":"Desrochers","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0090","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nrm2236","article-title":"The third dimension bridges the gap between cell culture and live tissue","volume":"8","author":"Pampaloni","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0095","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.drudis.2008.11.006","article-title":"3D cell culture opens new dimensions in cell-based assays","volume":"14","author":"Justice","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.yexcr.2012.09.012","article-title":"Differences in growth properties of endometrial cancer in three dimensional (3D) culture and 2D cell monolayer","volume":"319","author":"Chitcholtan","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1006\/excr.1996.0180","article-title":"Regulation of human (Caco-2) intestinal epithelial cell differentiation by extracellular matrix proteins","volume":"225","author":"Basson","year":"1996","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0110","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/ten.teb.2019.0334","article-title":"In vitro models of the small intestine: engineering challenges and engineering solutions","volume":"26","author":"Hewes","year":"2020","journal-title":"Tissue Eng. B Rev."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0115","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1007\/s10439-020-02470-8","article-title":"Materials and microenvironments for engineering the intestinal epithelium","volume":"48","author":"Snyder","year":"2020","journal-title":"Ann. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0120","doi-asserted-by":"crossref","DOI":"10.1088\/1758-5090\/ab0478","article-title":"Dynamic photopolymerization produces complex microstructures on hydrogels in a moldless approach to generate a 3D intestinal tissue model","volume":"11","author":"Castano","year":"2019","journal-title":"Biofabrication"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0125","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1080\/09637486.2019.1700940","article-title":"Development of a novel in vitro 3D intestinal model for permeability evaluations","volume":"71","author":"Zhang","year":"2020","journal-title":"Int. J. Food Sci. Nutr."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0130","doi-asserted-by":"crossref","first-page":"34514","DOI":"10.1039\/C8RA05992F","article-title":"A fast screening model for drug permeability assessment based on native small intestinal extracellular matrix","volume":"8","author":"Li","year":"2018","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0135","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1023\/A:1020483911355","article-title":"Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs","volume":"19","author":"Sun","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0140","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/onc.2013.154","article-title":"Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1\/2 and Akt phosphorylation and smallGTPase activity","volume":"33","author":"Cardoso","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0145","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.diff.2016.05.002","article-title":"Fibroblasts and myofibroblasts of the intestinal lamina propria in physiology and disease","volume":"92","author":"Roulis","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0150","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/BF01316489","article-title":"Contraction of collagen gels by intestinal epithelial cells depends on microfilament function","volume":"38","author":"Olson","year":"1993","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1161\/CIRCULATIONAHA.106.652859","article-title":"Endothelial function and dysfunction: testing and clinical relevance","volume":"115","author":"Deanfield","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144269","article-title":"Transient intervals of hyper-gravity enhance endothelial barrier integrity: impact of mechanical and gravitational forces measured electrically","volume":"10","author":"Szulcek","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0165","first-page":"119","article-title":"Human bronchial epithelial cells modulate collagen gel contraction by fibroblasts","volume":"274","author":"Mio","year":"1998","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0170","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1073\/pnas.85.13.4894","article-title":"Transforming growth factor beta stimulates collagen-matrix contraction by fibroblasts: implications for wound healing","volume":"85","author":"Montesano","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0175","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.crohns.2012.04.008","article-title":"Proinflammatory cytokines induce crosstalk between colonic epithelial cells and subepithelial myofibroblasts: implication in intestinal fibrosis","volume":"7","author":"Drygiannakis","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0180","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/jcp.1041440113","article-title":"Fibroblasts from wounds of different stages of repair vary in their ability to contract a collagen gel in response to growth factors","volume":"144","author":"Finesmith","year":"1990","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0185","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12931-017-0680-0","article-title":"A 3D epithelial-mesenchymal co-culture model of human bronchial tissue recapitulates multiple features of airway tissue remodeling by TGF-beta1 treatment","volume":"18","author":"Ishikawa","year":"2017","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0190","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/ijc.26090","article-title":"Endothelin-1 stimulates colon cancer adjacent fibroblasts","volume":"130","author":"Knowles","year":"2012","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0195","first-page":"699","article-title":"Transforming growth factor-beta 1 promotes contraction of collagen gel by bovine corneal fibroblasts through differentiation of myofibroblasts","volume":"39","author":"Kurosaka","year":"1998","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0200","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00005-014-0310-1","article-title":"The role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsis","volume":"63","author":"Kowalczyk","year":"2015","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0205","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s11010-005-3178-x","article-title":"Interaction of keratinocytes and fibroblasts modulates the expression of matrix metalloproteinases-2 and -9 and their inhibitors","volume":"269","author":"Sawicki","year":"2005","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/0014-4827(90)90305-T","article-title":"Beta 1 integrin-mediated collagen gel contraction is stimulated by PDGF","volume":"186","author":"Gullberg","year":"1990","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0215","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1590\/S0100-879X2005001000009","article-title":"Role of matrix metalloproteinases in the development of airway inflammation and remodeling","volume":"38","author":"Lagente","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0220","doi-asserted-by":"crossref","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","article-title":"Matrix metalloproteinases","volume":"274","author":"Nagase","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0225","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry","volume":"92","author":"Visse","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0230","first-page":"75","article-title":"Methods for detection of matrix metalloproteinases as biomarkers in cardiovascular disease","volume":"2","author":"Lopez-Avila","year":"2008","journal-title":"Clin. Med. Insights: Cardiol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0235","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1055\/s-0037-1616230","article-title":"Plasmin and matrix metalloproteinases in vascular remodeling","volume":"86","author":"Lijnen","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0240","first-page":"23","article-title":"Enterocyte differentiation marker intestinal alkaline phosphatase is a target gene of the gut-enriched Kruppel-like factor","volume":"286","author":"Hinnebusch","year":"2004","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0245","first-page":"63","article-title":"The secretion of intestinal alkaline phosphatase (IAP) from the enterocyte","volume":"29","author":"Alpers","year":"1994","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0250","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/0006-291X(91)91647-U","article-title":"Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells","volume":"175","author":"Artursson","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0255","first-page":"G123","article-title":"Sucrase-isomaltase gene expression along crypt-villus axis of human small intestine is regulated at level of mRNA abundance","volume":"262","author":"Traber","year":"1992","journal-title":"Am. J. Phys."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0260","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1128\/MCB.16.2.619","article-title":"An intestine-specific homeobox gene regulates proliferation and differentiation","volume":"16","author":"Suh","year":"1996","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0265","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2011.07.050","article-title":"Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium","volume":"141","author":"Sato","year":"2011","journal-title":"Gastroenteroloy"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0270","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0928-0987(95)00007-Z","article-title":"Co-cultures of human intestinal goblet (HT29-H) and absorptive (Caco-2) cells for studies of drug and peptide absorption","volume":"3","author":"Wikman-Larhed","year":"1995","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0275","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.vascn.2010.02.004","article-title":"Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design","volume":"61","author":"Chen","year":"2010","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0280","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40348-015-0028-0","article-title":"The clinical consequences of sucrase-isomaltase deficiency","volume":"3","author":"Cohen","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0285","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40348-016-0033-y","article-title":"The multiple roles of sucrase-isomaltase in the intestinal physiology","volume":"3","author":"Gericke","year":"2016","journal-title":"Mol. Cell. Pediatr."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0290","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.addr.2012.09.042","article-title":"Intestinal drug transporters: an overview","volume":"65","author":"Estudante","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0295","first-page":"151","article-title":"The transporters of intestinal tract and techniques applied to evaluate interactions between drugs and transporters","volume":"8","author":"Liu","year":"2013","journal-title":"Asian J. Pharmaceut. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2003.07.003","article-title":"The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability","volume":"21","author":"Chan","year":"2004","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0305","doi-asserted-by":"crossref","first-page":"730","DOI":"10.2174\/138920010794328850","article-title":"Targeting intestinal transporters for optimizing oral drug absorption","volume":"11","author":"Varma","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0310","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2217\/pgs.11.44","article-title":"Transporter-mediated drug-drug interactions","volume":"12","author":"Muller","year":"2011","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0315","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/1389200043489144","article-title":"Intestinal drug transporters: in vivo function and clinical importance","volume":"5","author":"Kunta","year":"2004","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0325","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/bdd.2025","article-title":"Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue","volume":"38","author":"Bruck","year":"2017","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0330","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ejpb.2014.03.017","article-title":"A tunable Caco-2\/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure","volume":"87","author":"Beduneau","year":"2014","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0335","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2174\/1568026013394886","article-title":"Strategies for absorption screening in drug discovery and development","volume":"1","author":"Bohets","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0340","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1124\/jpet.102.035014","article-title":"Regulation of expression of the multidrug resistance-associated protein 2 (MRP2) and its role in drug disposition","volume":"302","author":"Gerk","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0345","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1472-8206.2007.00550.x","article-title":"Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR","volume":"21","author":"Maubon","year":"2007","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0350","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0355","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1003515413550","article-title":"Peptide transporter in the rat small intestine: ultrastructural localization and the effect of starvation and administration of amino acids","volume":"31","author":"Ogihara","year":"1999","journal-title":"Histochem. J."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0360","first-page":"913","article-title":"Research progress in the organic cation transporters","volume":"36","author":"Shu","year":"2011","journal-title":"Zhong Nan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0365","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1046\/j.1365-201X.1998.0248f.x","article-title":"Integrity and metabolism of human ileal mucosa in vitro in the Ussing chamber","volume":"162","author":"S\u00f6derholm","year":"1998","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0370","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0169-409X(00)00128-9","article-title":"Caco-2 monolayers in experimental and theoretical predictions of drug transport","volume":"46","author":"Artursson","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0375","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1517\/17425255.4.4.395","article-title":"The Caco-2 cell monolayer: usefulness and limitations","volume":"4","author":"Sun","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0380","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1038\/s41598-018-24148-x","article-title":"Study of mucin turnover in the small intestine by in vivo labeling","volume":"8","author":"Schneider","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0385","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s11894-010-0131-2","article-title":"Intestinal goblet cells and mucins in health and disease: recent insights and progress","volume":"12","author":"Kim","year":"2010","journal-title":"Curr. Gastroenterol. Rep."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0390","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1002\/jps.1111","article-title":"HT29-MTX and Caco-2\/TC7 monolayers as predictive models for human intestinal absorption: role of the mucus layer","volume":"90","author":"Pontier","year":"2001","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0395","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.bbamem.2006.06.004","article-title":"A kinetic study of Rhodamine123 pumping by P-glycoprotein","volume":"1758","author":"Wang","year":"2006","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0400","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1382-6689(01)00122-3","article-title":"Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active and passive transport with the human colon carcinoma Caco-2 cell line","volume":"11","author":"Versantvoort","year":"2002","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0405","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2009.09.014","article-title":"Induction of intestinal multidrug resistance-associated protein 2 (Mrp2) by spironolactone in rats","volume":"623","author":"Ruiz","year":"2009","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0410","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s11095-008-9789-7","article-title":"Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein","volume":"26","author":"Dahan","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0415","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/jps.24447","article-title":"In situ perfusion model in rat colon for drug absorption studies: comparison with small intestine and Caco-2 cell model","volume":"104","author":"Lozoya-Agullo","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0420","series-title":"Colchicine, Textbook of Autoinflammation","first-page":"729","author":"Ben-Chetrit","year":"2018"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0425","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.biomaterials.2017.03.023","article-title":"Improvement of paracellular transport in the Caco-2 drug screening model using protein-engineered substrates","volume":"129","author":"DiMarco","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2021.11.048_bb0430","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1023\/A:1018903931777","article-title":"Selective paracellular permeability in two models of intestinal absorption: cultured monolayers of human intestinal epithelial cells and rat intestinal segments","volume":"10","author":"Artursson","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0435","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2016.09.061","article-title":"Segmental-dependent permeability throughout the small intestine following oral drug administration: single-pass vs Doluisio approach to in-situ rat perfusion","volume":"515","author":"Lozoya-Agullo","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ijpharm.2017.05.018","article-title":"Investigating drug absorption from the colon: single-pass vs doluisio approaches to in-situ rat large-intestinal perfusion","volume":"527","author":"Lozoya-Agullo","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0445","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.xphs.2020.07.001","article-title":"The past, present and future of intestinal in vitro cell Systems for Drug Absorption Studies","volume":"110","author":"Youhanna","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0450","doi-asserted-by":"crossref","first-page":"3246","DOI":"10.1002\/jps.22080","article-title":"Towards prediction of in vivo intestinal absorption using a 96-well Caco-2 assay","volume":"99","author":"Skolnik","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0455","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2015.01.014","article-title":"In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: investigation of the single-pass vs. the Doluisio experimental approaches","volume":"480","author":"Lozoya-Agullo","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0460","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1124\/dmd.109.028282","article-title":"Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine","volume":"37","author":"Dahan","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0465","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1021\/mp2004912","article-title":"pH-dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery","volume":"9","author":"Varma","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0470","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1002\/jps.24258","article-title":"Direct in vivo human intestinal permeability (Peff) determined with different clinical perfusion and intubation methods","volume":"104","author":"Dahlgren","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0475","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/bdd.1848","article-title":"Structure-based prediction of human intestinal membrane permeability for rapid in silico BCS classification","volume":"34","author":"Sun","year":"2013","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0480","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejps.2017.06.033","article-title":"Comparison of segmental-dependent permeability in human and in situ perfusion model in rat","volume":"107","author":"Ruiz-Picazo","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0485","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1021\/js9803205","article-title":"MDCK (Madin-Darby canine kidney) cells: a tool for membrane permeability screening","volume":"88","author":"Irvine","year":"1999","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0490","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/1087057107308892","article-title":"Development of in vitro pharmacokinetic screens using Caco-2, human hepatocyte, and Caco-2\/human hepatocyte hybrid systems for the prediction of oral bioavailability in humans","volume":"12","author":"Cheng","year":"2007","journal-title":"J. Biomol. Screen."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0495","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1023\/A:1011930411574","article-title":"Correlating partitioning and Caco-2 cell permeability of structurally diverse small molecular weight compounds","volume":"15","author":"Yazdanian","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0500","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1021\/mp070028i","article-title":"Biopharmaceutics classification of selected beta-blockers: solubility and permeability class membership","volume":"4","author":"Yang","year":"2007","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2021.11.048_bb0505","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1007\/s11095-009-9924-0","article-title":"The role of transporters in the pharmacokinetics of orally administered drugs","volume":"26","author":"Shugarts","year":"2009","journal-title":"Pharm. Res."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T16:17:15Z","timestamp":1759162635000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":101,"alternative-id":["S0168365921006519"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.048","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All layers matter: Innovative three-dimensional epithelium-stroma-endothelium intestinal model for reliable permeability outcomes","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.11.048","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}